Teleflex (TFX)
(Delayed Data from NYSE)
$239.18 USD
-0.36 (-0.15%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $239.20 +0.02 (0.01%) 7:58 PM ET
2-Buy of 5 2
B Value F Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$239.18 USD
-0.36 (-0.15%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $239.20 +0.02 (0.01%) 7:58 PM ET
2-Buy of 5 2
B Value F Growth B Momentum C VGM
Zacks News
Can Abbott Laboratories (ABT) Pull a Surprise in Q2 Earnings?
by Zacks Equity Research
Abbott Laboratories (ABT) is scheduled to report second-quarter 2017 results before the opening bell on Jul 20.
Zacks Industry Outlook Highlights: Teleflex, Medtronic, Johnson & Johnson, Hologic and Wright Medical
by Zacks Equity Research
Zacks Industry Outlook Highlights: Teleflex, Medtronic, Johnson & Johnson, Hologic and Wright Medical
Teleflex to Introduce Arrow AC3 Optimus at EuroPCR, Paris
by Zacks Equity Research
Teleflex Inc. (TFX) announced plans to introduce Arrow AC3 Optimus Intra-Aortic Balloon Pump at the European Association for Percutaneous Cardiovascular Interventions Course (EuroPCR) in Paris during May 16--19.
Medical Product Stocks' Earnings Due on May 4: ABMD & More
by Zacks Equity Research
Here we discuss four major Medical Product bigwigs, which are scheduled to release their earnings results on May 4.
Invest in These Top 4 GARP Stocks Now
by Zacks Equity Research
The GARP approach prefers stocks that are priced below the market or any reasonable target determined by fundamental analysis.
After ISRG Q1 Earnings, 3 Medical Instrument Stocks Looking Up
by Zacks Equity Research
While the Medical Instrument industry has been oscillating between hope and despair, let us take a look at three stocks which are expected to put up an impressive show this earnings season like Intuitive Surgical.
Teleflex (TFX) Acquires Medical Device Provider Pyng Medical
by Zacks Equity Research
Teleflex Inc. (TFX), a global provider of medical technologies, announced that it has acquired Pyng Medical Corporation.
Moving Average Crossover Alert: Teleflex (TFX)
by Zacks Equity Research
Teleflex (TFX) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
Teleflex (TFX) Gains FDA Approval for TrapLiner Catheter
by Zacks Equity Research
Teleflex Incorporated (TFX) recently announced 510(k) clearance for its TrapLiner Catheter from the US FDA for a full fledged commercial launch in the country.
MedTech Stocks' Earnings Due on Feb 23: TFX, SAUHF, BIO, PDCO
by Zacks Equity Research
Let's take a look at the major MedTech stocks slated to release their Oct-Dec 2016 numbers on Feb 23.
Teleflex Launches LMA Gastro Airway, FDA Okays Arrow VPS
by Zacks Equity Research
Teleflex Inc. (TFX) recently announced the launch of LMA Gastro Airway with Cuff Pilot Technology and the receipt of 510(k) approval from the U.S. FDA for its Arrow VPS Rhythm device.
Company News for December 05, 2016
by Zacks Equity Research
Companies in the News are: BIG,VASC,TFX,P,SIRI,SBUX